Approved regimens are not sex-specific. Product, indication, kidney/gastrointestinal history, other diabetes medicines and tolerability determine prescribing.
Prescription ingredient
Metabolic research
Semaglutide
An active ingredient used in authorized prescription products for specific diabetes, weight-management and cardiovascular-risk indications.
Semaglutide5 mg / 10 mg
Add a Featured Image in WordPress to replace this product placeholder.
ClassificationGLP-1 receptor agonist
Catalogue strength5 mg / 10 mg
Current contextPrescription ingredient
What it is
An active ingredient used in authorized prescription products for specific diabetes, weight-management and cardiovascular-risk indications.
Its catalogue classification is glp-1 receptor agonist. Status and formulation matter: a research-labelled vial is not automatically equivalent to an authorized prescription medicine containing a similarly named ingredient.
What it is studied or used for
- Type 2 diabetes management
- Chronic weight management in eligible patients
- GLP-1 receptor pharmacology
A research topic is not proof of a health benefit. Evidence can range from cell and animal models to controlled human trials, and those levels should not be treated as equivalent.
How it is used or administered
Authorized semaglutide products include different injectable and oral formulations with different schedules. A research vial must not be treated as interchangeable with an approved product.
Dosing context for men and women
Approved regimens are not sex-specific. Pregnancy planning, pregnancy and breastfeeding require specific medical review; semaglutide is not a cosmetic self-treatment.
Why no universal number? Dose depends on the exact formulation, legal status, indication, concentration, patient factors and monitoring. Publishing a single male or female number would be misleading and unsafe.
Active shelf life and storage
Follow the printed expiry and the dispensing label. Shelf life cannot be transferred between brands, concentrations, compounded products or reconstituted preparations.
Follow the manufacturer and pharmacy label for the exact dispensed formulation. Temperature limits can differ between tablets, creams and injectable products.
What it may be paired with
Do not combine with another semaglutide product or another GLP-1/GIP agonist unless a prescriber specifically directs it. Hypoglycaemia risk can rise with insulin or sulfonylureas.
Safety boundary
The presence of an approved active ingredient does not establish that every formulation or seller is authorized.
Continue with primary sources
Evidence and regulatory status change. Verify the exact active ingredient, formulation and jurisdiction before drawing conclusions.
Product availability
View Semaglutide on the main site ↗
Ready to leave the education library?
Purchasing, pricing, shipping and product-specific lot information are handled on the main Cryos Bio Labs website.